14th April 2016 – The world renown International Liver Congress 2016 started yesterday. One of the current highlights is a study by DNDi (Drugs for Neglected Diseases initiative) which introduced a new ravidasvir and sofosbuvir combo for treating Hepatitis C. According to clinical studies done on 300 patients in Egypt, the new Hepatitis C combo is […]
